Sichuan Goldstone Asia Pharmaceutical, Inc.

  • Market Cap: Small Cap
  • Industry: Miscellaneous
  • ISIN: CNE100001YX5
CNY
11.60
0.08 (0.69%)
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-summaryPrice Point
High/Low

1Day

52 Week

Valuation
Technical
Day's Volume

CASH

N/A

Shareholding

FII

N/A

DII

N/A

Promoter

N/A

iScoreScore
Click here to find our call on this stock
Strong Sell
Sell
Hold
Buy
Strong Buy

Dashboard

1

Positive results in Sep 25

  • NET PROFIT(HY) At CNY 31.11 MM has Grown at 193.82%
  • RAW MATERIAL COST(Y) Fallen by -24.66% (YoY)
2

With ROE of 4.44%, it has a fair valuation with a 1.53 Price to Book Value

3

Market Beating Performance

stock-summaryMojo Parameters

Mojo Parameters

Stock DNA

stock-summary
Industry

Miscellaneous

stock-summary
Market cap

CNY 2,112 Million (Small Cap)

stock-summary
P/E

34.00

stock-summary
Industry P/E

NA

stock-summary
Dividend Yield

0.66%

stock-summary
Debt Equity

-0.13

stock-summary
Return on Equity

4.87%

stock-summary
Price to Book

0.84

Revenue and Profits:
Net Sales:
331 Million
(Quarterly Results - Mar 2026)
Net Profit:
116 Million
stock-summaryTotal Returns
Total Returns (Price + Dividend) stock-summary
TimePeriod
Price Return
Dividend Return
Total Return
3 Months
7.31%
0%
7.31%
6 Months
0.78%
0%
0.78%
1 Year
45.0%
0%
45.0%
2 Years
24.46%
0%
24.46%
3 Years
-16.12%
0%
-16.12%
4 Years
32.88%
0%
32.88%
5 Years
27.75%
0%
27.75%

Sichuan Goldstone Asia Pharmaceutical, Inc. for the last several years.

Risk Adjusted Returns v/s stock-summary
stock-summaryNews & Corporate Actions

News

Icon
No Recent News for the Company

Announcements stock-summary

Icon
No announcement available

Corporate Actions stock-summary

Icon
No corporate action available
stock-summaryKey Factors

Quality key factors stock-summary

Factor
Value
Sales Growth (5y)
3.75%
EBIT Growth (5y)
56.69%
EBIT to Interest (avg)
100.00
Debt to EBITDA (avg)
0
Net Debt to Equity (avg)
-0.09
Sales to Capital Employed (avg)
0.45
Tax Ratio
21.22%
Dividend Payout Ratio
30.21%
Pledged Shares
0
Institutional Holding
0
ROCE (avg)
7.80%
ROE (avg)
5.07%

Valuation key factors

Factor
Value
P/E Ratio
34
Industry P/E
Price to Book Value
1.53
EV to EBIT
26.77
EV to EBITDA
15.00
EV to Capital Employed
1.59
EV to Sales
3.38
PEG Ratio
0.64
Dividend Yield
0.36%
ROCE (Latest)
5.94%
ROE (Latest)
4.44%

Technicals key factors

Indicator
Weekly
Monthly
MACD
Bullish
Bullish
RSI
No Signal
No Signal
Bollinger Bands
Bullish
Bullish
Moving Averages
Mildly Bearish (Daily)
KST
Mildly Bullish
Bullish
Dow Theory
No Trend
No Trend
OBV
Mildly Bullish
Mildly Bullish
stock-summary Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish  Turned 
stock-summaryShareholding
Shareholding Snapshotstock-summary
Icon
No data for shareholding present.
Shareholding Compare (%holding) stock-summary
Icon
No data for shareholding present.
stock-summaryFinancial
[
  {
    "link": "quarterly",
    "btn_text": "All Quarterly Results",
    "header": "Quarterly Results Snapshot (Consolidated) - Mar'26 - QoQ",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "QoQ Growth in quarter ended Mar 2026 is 0.48% vs 52.17% in Dec 2025",
        "dir": -1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "QoQ Growth in quarter ended Mar 2026 is 243.32% vs 10.13% in Dec 2025",
        "dir": 1
      }
    ],
    "table": {
      "header": [
        "Mar'26",
        "Dec'25",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "331.50",
          "val2": "329.90",
          "chgp": "0.48%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "124.00",
          "val2": "60.70",
          "chgp": "104.28%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "0.20",
          "val2": "0.40",
          "chgp": "-50.00%",
          "chgp_class": "positive"
        },
        {
          "field": "Exceptional Items",
          "val1": "1.50",
          "val2": "2.10",
          "chgp": "-28.57%",
          "chgp_class": "negative"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "115.70",
          "val2": "33.70",
          "chgp": "243.32%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "374.20%",
          "val2": "104.50%",
          "chgp": "26.97%",
          "chgp_class": "positive"
        }
      ]
    }
  },
  {
    "link": "annual",
    "btn_text": "All Annual Results",
    "header": "Annual Results Snapshot (Consolidated) - Dec'25",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in year ended Dec 2025 is -5.84% vs -8.80% in Dec 2024",
        "dir": 1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "YoY Growth in year ended Dec 2025 is 45.15% vs -26.59% in Dec 2024",
        "dir": 1
      }
    ],
    "table": {
      "header": [
        "Dec'25",
        "Dec'24",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "1,028.70",
          "val2": "1,092.50",
          "chgp": "-5.84%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "241.60",
          "val2": "231.20",
          "chgp": "4.50%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "1.90",
          "val2": "1.50",
          "chgp": "26.67%",
          "chgp_class": "negative"
        },
        {
          "field": "Exceptional Items",
          "val1": "7.00",
          "val2": "-0.30",
          "chgp": "2,433.33%",
          "chgp_class": "positive"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "128.60",
          "val2": "88.60",
          "chgp": "45.15%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "132.60%",
          "val2": "114.10%",
          "chgp": "1.85%",
          "chgp_class": "positive"
        }
      ]
    }
  }
]

Quarterly Results Snapshot (Consolidated) - Mar'26 - QoQstock-summary

Mar'26
Dec'25
Change(%)
Net Sales
331.50
329.90
0.48%
Operating Profit (PBDIT) excl Other Income
124.00
60.70
104.28%
Interest
0.20
0.40
-50.00%
Exceptional Items
1.50
2.10
-28.57%
Consolidate Net Profit
115.70
33.70
243.32%
Operating Profit Margin (Excl OI)
374.20%
104.50%
26.97%
USD in Million.
Direction Arrows
Net Sales

QoQ Growth in quarter ended Mar 2026 is 0.48% vs 52.17% in Dec 2025

Direction Arrows
Consolidated Net Profit

QoQ Growth in quarter ended Mar 2026 is 243.32% vs 10.13% in Dec 2025

Annual Results Snapshot (Consolidated) - Dec'25stock-summary

Dec'25
Dec'24
Change(%)
Net Sales
1,028.70
1,092.50
-5.84%
Operating Profit (PBDIT) excl Other Income
241.60
231.20
4.50%
Interest
1.90
1.50
26.67%
Exceptional Items
7.00
-0.30
2,433.33%
Consolidate Net Profit
128.60
88.60
45.15%
Operating Profit Margin (Excl OI)
132.60%
114.10%
1.85%
USD in Million.
Direction Arrows
Net Sales

YoY Growth in year ended Dec 2025 is -5.84% vs -8.80% in Dec 2024

Direction Arrows
Consolidated Net Profit

YoY Growth in year ended Dec 2025 is 45.15% vs -26.59% in Dec 2024

stock-summaryCompany CV
About Sichuan Goldstone Asia Pharmaceutical, Inc. stock-summary
stock-summary
Sichuan Goldstone Asia Pharmaceutical, Inc.
Miscellaneous
No Details Available.
Company Coordinates stock-summary
Icon
No Company Details Available